Drug Approval | August 05, 2023
USFDA approves Merck’s ERVEBO for use in children 12 months of age and older
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
_256_384.jpg)
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
The workshop strived to sensitize states and various stakeholder departments regarding their role in the implementation of National Patient Safety Implementation Framework, as well as augment capacity building of health care professionals
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
